Omics, MDx Stocks Rise 5 Percent in June Led by Exact Sciences, Sequenom, PacBio, and GenMark | GenomeWeb

NEW YORK (GenomeWeb) – After a mixed picture in May, shares of firms in the omics research tools and MDx space rebounded in June as the GenomeWeb Daily News Index improved by more than 5 percent month over month.

Exact Sciences (+26 percent) paced the gainers, followed by Sequenom (+26 percent), Pacific Biosciences (+25 percent), and GenMark Diagnostics (+23 percent).

Vermillion (-4 percent) and CombiMatrix (-4 percent) were the biggest decliners in June.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.